Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Sell
206
-98
-32% -$11.9K ﹤0.01% 1513
2026
Q1
$49.7K Sell
304
-564
-65% -$86.7K ﹤0.01% 1096
2025
Q4
$151K Buy
868
+661
+319% +$121K ﹤0.01% 715
2025
Q3
$29.8K Buy
207
+166
+405% +$20.3K ﹤0.01% 1296
2025
Q2
$4.13K Buy
41
+1
+3% +$76 ﹤0.01% 2081
2025
Q1
$3.05K Buy
40
+17
+74% +$1.3K ﹤0.01% 2107
2024
Q4
$1.59K Buy
+23
New +$1.66K ﹤0.01% 2390

Other funds holding INSM

SBI Securities's INSM Position: Q2 2026 in Review

SBI Securities reduced its Insmed (INSM) stake by 32% in Q2 2026, selling an estimated $11.9K and leaving 206 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

SBI Securities first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $151K in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • SBI Securities held 206 shares of Insmed worth $22K as of Q2 2026.
  • SBI Securities sold 98 Insmed shares in Q2 2026, an estimated $11.9K.
  • Insmed made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1513 holding.
  • SBI Securities first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Insmed position peaked at $151K in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.